Related Experiment Video
Updated: Oct 17, 2025
07:41
Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
Published on: July 12, 2024
2.7K
Microneedle-mediated therapy for cardiovascular diseases.
Ruyi Zhou1, Jicheng Yu2, Zhen Gu3,4,5,6
1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Drug Delivery and Translational Research
|October 12, 2021
Summary
Microneedles offer a promising transdermal drug delivery method for cardiovascular diseases, improving therapeutic efficacy over conventional methods. This review explores microneedle strategies for treating hypertension, atherosclerosis, thrombus, and myocardial conditions.
Area of Science:
- Biomedical Engineering
- Cardiovascular Medicine
- Drug Delivery Systems
Background:
- Cardiovascular diseases represent a significant global health challenge.
- Conventional treatments like intramyocardial injections and vascular devices have limited efficacy due to poor drug retention and short release times.
- Microneedles offer a minimally invasive, transdermal approach with controlled and sustained drug release.
Purpose of the Study:
- To review current microneedle-based strategies for treating cardiovascular diseases.
- To focus on applications in hypertension, atherosclerosis, thrombus, and myocardial diseases.
- To discuss current limitations and future perspectives for microneedle technology in cardiovascular therapy.
Main Methods:
- Literature review of microneedle applications in cardiovascular disease treatment.
- Analysis of strategies for drug delivery via microneedles.
- Discussion of limitations and future directions.
Main Results:
- Microneedles demonstrate potential for enhanced drug delivery and therapeutic effects in cardiovascular conditions.
- Specific applications reviewed include hypertension, atherosclerosis, thrombus, and myocardial diseases.
- Current limitations and future research avenues for advanced microneedle systems are identified.
Conclusions:
- Microneedles represent a promising advancement in transdermal drug delivery for cardiovascular diseases.
- Further development is needed to overcome current limitations and fully realize the potential of next-generation microneedles.
- Microneedle technology holds significant promise for improving cardiovascular disease management.
